Chronic Respiratory Diseases: Lung and Respiratory Disease

Author(s): Dr. Joil Jemas

Barely any examinations have evaluated the personal satisfaction (QOL) connected with constant respiratory illnesses in the old. A questionnaire was completed by elderly residents of 53 selected nursing homes as part of the geriatric study on the health effects of air quality in elderly care centers (GERIA) study. It remembered different segments for request to survey respiratory protests, QOL (World Wellbeing Association QOL (WHOQOL)- BREF), and the mental and discouragement status. The result factors were the presence of a score lower than 50 (<50) in every one of the WHOQOL-BREF spaces (actual wellbeing, mental wellbeing, social connections, and ecological wellbeing). Potential risk factors included chronic bronchitis, frequent cough, current wheezing, asthma, and allergic rhinitis. The sample that was surveyed consisted of (n = 887) 79% women, with a mean age of 84 (SD: 7 years). In the multivariable analysis, wheezing in the previous year was correlated with a physical domain score of 50 (odds ratio (OR): 2.03, interval of confidence (CI): 1.25–3.31) as well as asthma 1.95, CI: 1.12–3.38). A frequent cough was associated with the psychological domain (OR: 1.43, CI: 0.95–2.91). Chronic bronchitis was associated with a score of 50 in the environmental domain (OR: 2.89, CI: 1.34–6.23) as well as emphysema 3.89, CI: 1.27–11.88). According to these findings, the presence of respiratory conditions appears to be a significant risk factor for low QOL in elderly residents of nursing homes. Both communicable and noncommunicable chronic respiratory diseases (CRDs) account for the majority of global mortality, morbidity, economic and societal burden, and disability-adjusted life years (DALYs). Multiple parts of the respiratory system are affected by CRDs, including the airways, parenchyma, and pulmonary vasculature. Even though noncommunicable respiratory diseases like asthma, COPD, interstitial lung disease (ILD), cystic fibrosis (CF), and lung cancer (LC) account for a significant portion of the disease burden, the therapies that are currently available only focus on relieving the symptoms of diseases rather than providing the most effective treatment and/or prevention.